AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies

Go back to AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
(NASDAQ: ANAB) Delayed: 58.00 +3.85 (7.11%)
Previous Close $54.15    52 Week High
Open $53.43    52 Week Low
Day High $58.62    P/E N/A 
Day Low $53.17    EPS
Volume 732,652